Marksans Pharma has informed that it enclosed the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025 received from Bigshare Services, Registrar and Transfer Agent of the Company.
The above information is a part of company’s filings submitted to BSE.